The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, has stopped one arm of a three arm multi-center, clinical trial studying treatments for the lung-scarring disease idiopathic pulmonary fibrosis (IPF) for safety concerns.

Related posts:

  1. Supported studies show online course helps reduce harmful college drinking An online alcohol prevention course can help reduce harmful drinking among college freshmen, but the benefits in the fall don’t last through the spring, according to a study supported by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), part of the National Institutes of Health....
  2. Six-month drug regimen cuts HIV isk for breastfeeding infants Giving breastfeeding infants of HIV-infected mothers a daily dose of the antiretroviral drug nevirapine for six months halved the risk of HIV transmission to the infants at age 6 months compared with giving infants the drug daily for six weeks, according to preliminary clinical trial data presented today....
  3. Medicare Card, Stroke Prevention Study, Children with Sickle Cell Anemia, Iron Overload Stopped Early The National Heart, Lung, and Blood Institute (NHLBI) has stopped a clinical trial evaluating a new approach to reduce the risk of recurrent stroke in children with sickle cell anemia and iron overload because of evidence that the new treatment was unlikely to prove better than the existing treatment....
  4. Possible alternate therapy for adults with poorly controlled asthma A drug commonly used for the treatment of chronic obstructive pulmonary disease (COPD) successfully treats adults whose asthma is not well-controlled on low doses of inhaled corticosteroids, reported researchers supported by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health....
  5. Medicare: COPD awareness continues to rise, new NIH survey finds Awareness of COPD (chronic obstructive pulmonary disease), the nation’s third leading killer, continues to rise in the United States, according to the results of a Web-based survey released today by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health....
  6. Medicare, New NIH data show gains in COPD awareness The number of Americans who report being aware of chronic obstructive pulmonary disease, or COPD, increased by 4 percentage points between 2008 and 2010, but many people at risk are still unaware of the disease, according to mailed survey results released today by the National Heart, Lung, and Blood Institute (NHLBI), part of the National […]...
  7. Clinical trial stopped on combination cholesterol treatment The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health has stopped a clinical trial studying a blood lipid treatment 18 months earlier than planned. The trial found that adding high dose, extended-release niacin to statin treatment in people with heart and vascular disease, did not reduce the risk of cardiovascular […]...
  8. Study finds hospitalizations increase for alcohol and drug overdoses Hospitalizations for alcohol and drug overdoses — alone or in combination — increased dramatically among 18- to 24-year-olds between 1999 and 2008, according to a study by researchers at the National Institute on Alcohol Abuse and Alcoholism (NIAAA), part of the National Institutes of Health....
  9. Medicare, Succimer found ineffective for removing mercury Succimer, a drug used for treating lead poisoning, does not effectively remove mercury from the body, according to research supported by the National Institutes of Health. Some families have turned to succimer as an alternative therapy for treating autism....
  10. Funded study shows 20 percent reduction in lung cancer mortality with low-dose CT compared to chest X-ray Scientists have found a 20 percent reduction in deaths from lung cancer among current or former heavy smokers who were screened with low-dose helical computed tomography (CT) versus those screened by chest X-ray. The primary research results from the National Lung Screening Trial (NLST) were published online today in the New England Journal of Medicine. […]...
  11. Therapeutics for Rare and Neglected Diseases Program announces next round of drug development projects Researchers will begin drug development projects for rare and neglected diseases that include potential treatments for a musculoskeletal disorder, a cognitive dysfunction disorder, a virus that affects the central nervous system of newborns, a parasitic worm infection, a form of muscular dystrophy and a rare lung disease....
  12. Medicare, Independent panel discourages routine use of treatment regimen for premature infants Premature infants often suffer from respiratory problems due to their underdeveloped lungs. Over the past decade, many of these infants have been treated with inhaled nitric oxide — a treatment designed to ease breathing by widening blood vessels in the lungs. This week, an independent panel convened by the National Institutes of Health determined that […]...
  13. Teen musicians in drug treatment win 2012 Grammy experience Two teens with powerful stories about their experience in drug treatment have been awarded the top distinction in the MusiCares and Grammy Foundation’s Teen Substance Abuse Awareness through Music Contest. The annual contest was created to celebrate National Drug Facts Week and is coordinated by the National Institute on Drug Abuse (NIDA), part of the […]...
  14. Apply Online for Extra Help with Medicare Prescription Drug Plan Costs Apply Online for Extra Help with Medicare Prescription Drug Plan Costs...
  15. Researchers show how anti-HIV drug acts to block herpes virus An anti-HIV drug also discovered to stop the spread of the genital herpes virus does so by disabling a key DNA enzyme of the herpes virus, according to findings by researchers at the National Institutes of Health and other institutions....